Baidu
map
INT J ENDOCRINOL 润色咨询

International Journal of Endocrinology

出版年份:2009 年文章数:1942 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:3.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2024-10-07 ms5000001996918480 来自江苏省

    偏重的研究方向:内分泌疾病
    经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2021-11-07 ms4000001135259825

    我已经五个月了,一直是under review,正常吗,在线等,要等哭了。

    4

    展开4条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2021-12-30 大道至简111

    投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2023-10-18 ms1000001042631374 来自江西省

    偏重的研究方向:糖尿病;临床
    经验分享:15天 还在AE invited....

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2024-04-01 ms8000000748328144 来自云南省

    被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2023-07-02 我爱写歌词 来自山东省

    审稿速度:3.0
    经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。

    4

    展开4条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2023-12-19 12112347m62(暂无昵称) 来自浙江省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:甲状腺
    经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2022-01-18 120a0830m36暂无昵称

    被Clinical endocrinology 推荐转投,要不要接受。。。

    5

    展开5条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2023-05-20 cq2019 来自湖北省

    偏重的研究方向:甲状腺
    经验分享:投稿9天,还没有指派学术编辑

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2229671, encodeId=124222296e166, content=偏重的研究方向:内分泌疾病<br>经验分享:2.23 Submitted (4.23 催稿) 4.24 Reviewers Invited 5.14 Under review 5.27 Pending Approval 5.29 Major Revision 6.20 修回 Under review 6.22 Pending Approval(6.22-8.4全部显示此状态只有以下时间变动) 6.28(Reviewers Invited邀请审稿人) 7.5(Under review审稿人接受审稿并审稿) 7.31(Pending Approval审稿人意见返回) 8.5 Minor Revision 8.8 修回 Pending Approval 9.4 Pending Approval(第二天格式审查修改参考文献格式) 9.6 Submit Updates(接收,提交正确格式稿件、图片和表格,缴纳版面费) 9.6 返修 Updates Submitted International Journal of Endocrinology投稿分享: 1.此杂志很难邀请到编辑,投稿2个月没有邀请到编辑处理稿件,给杂志社发邮件催稿后当天分配编辑并送审,速度很快。 2.一审意见回来只有一个审稿人,都是比较好改的意见,无需大动干戈,20天后修回。 3.一审修回后状态立马变成Under Review,2天后审稿人完成审稿,并且持续显示Pending Approval状态1个多月,期间只有日期的变动,杂志社发来邮件:I am writing regarding your manuscript XXX, entitled XXX. It is taking us longer than expected to send you an editorial decision for your manuscript. As standard practice, we perform rigorous peer review integrity checks as part of the editorial process. These checks can sometimes incur delays. 目前应该是必须需要2个审稿人审稿才行。后面二审发来邮件说第一个审稿人已经同意发表,又多出个新的审稿人,给了小修意见,并且也很好修改,因此推测Pending Approval时间变动状态应为6.28(Reviewers Invited邀请审稿人)、7.5(Under review审稿人接受审稿并审稿)、7.31(Pending Approval审稿人意见返回)。 4.二审修回后状态一直显示Pending approval接近一个月,推测编辑放假了,半个月的时候发邮件催稿说已经通知编辑邀请审稿人,直到快一个月的时候日期更新了,更新的第二天格式审查编辑发邮件说参考文献格式不对要求修改并直接把修改后文章发给她,当天返修后第二天收到三封邮件:1接收,2系统内提交正确格式稿件、图片和表格,3缴纳版面费。推测二修稿件没有给二审审稿人审稿,编辑直接决定接收。发邮件当天系统重新提交修改稿件并缴纳了版面费。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3ccd5416444, createdName=ms5000001996918480, createdTime=Mon Oct 07 17:35:35 CST 2024, time=2024-10-07, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1067768, encodeId=8d4f106e76855, content=我已经五个月了,一直是under review,正常吗,在线等,要等哭了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43585514003, createdName=ms4000001135259825, createdTime=Sun Nov 07 11:20:36 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1178938, encodeId=cc1f11e8938b8, content=投稿2个半月了,状态还是V1(Academic Editor Invited),难道杂志还没找到审稿人吗?这种情况正常吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=110, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201115/937b8f20c0774529b47007cd6100793f/bded1fa23ee5467e9d40e08b043a7890.jpg, createdBy=24402559221, createdName=大道至简111, createdTime=Thu Dec 30 18:39:57 CST 2021, time=2021-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2163606, encodeId=320f216360695, content=偏重的研究方向:糖尿病;临床<br>经验分享:15天 还在AE invited...., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8cf08742257, createdName=ms1000001042631374, createdTime=Wed Oct 18 20:24:25 CST 2023, time=2023-10-18, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2196503, encodeId=b8d521965034f, content=被Clinical endocrinology 推荐转投,我同意了,,请问又从哪里登录查看稿件动态呢?小白求帮助,,,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc559038572, createdName=ms8000000748328144, createdTime=Mon Apr 01 20:42:36 CST 2024, time=2024-04-01, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2145939, encodeId=5b372145939df, content=审稿速度:3.0<br>经验分享:投稿3个多月,催了一次,回复说找不到审稿人,让自己推荐审稿人,也是醉了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQmV24MRDY7wn75cHicnUffTMDfpXJuEV3sNaw70NtickSVHcMDAxV6UZ7ROKn78GcWwA/132, createdBy=034f2309606, createdName=我爱写歌词, createdTime=Sun Jul 02 10:20:42 CST 2023, time=2023-07-02, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2175813, encodeId=cfa321e5813ae, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:甲状腺<br>经验分享:2023年6月中旬投稿,10月初 一审给大修,11月下旬返修后显示under review,两周后变成pending approval,到目前持续了16天了没有改变,不知道能不能接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/5aea3dc4251f1ef471c5d5f5a2e6ca51/40d445eef080ed392185b807ff427f40.jpg, createdBy=a8932225910, createdName=12112347m62(暂无昵称), createdTime=Tue Dec 19 14:25:06 CST 2023, time=2023-12-19, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1185640, encodeId=6e08118564089, content=被Clinical endocrinology 推荐转投,要不要接受。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=675c2195011, createdName=120a0830m36暂无昵称, createdTime=Tue Jan 18 15:33:16 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2138051, encodeId=847b2138051ba, content=偏重的研究方向:甲状腺<br>经验分享:投稿9天,还没有指派学术编辑, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5fd51628848, createdName=cq2019, createdTime=Sat May 20 19:04:50 CST 2023, time=2023-05-20, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2151959, encodeId=3e0821519598a, content=20多天一直是pending approval,大概需要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLialg5UCybAynKPP9tvWhTj2404jIJgEN2uu4oQLlXDiaRwI904aiaUahh3Cwtndog3oJfFXVicsTEPg/132, createdBy=6edb2240528, createdName=Peter忘记我, createdTime=Wed Aug 09 16:07:26 CST 2023, time=2023-08-09, status=1, ipAttribution=河北省)]
    2023-08-09 Peter忘记我 来自河北省

    20多天一直是pending approval,大概需要等多久

    0

共125条页码: 1/13页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map